Since its development and release in 2019, the Society for Cardiovascular Angiography and
Interventions (SCAI) shock stage classification for adult patients has been widely cited and …

Importance Cardiogenic shock affects between 40 000 and 50 000 people in the US per
year and is the leading cause of in-hospital mortality following acute myocardial infarction …

Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is
increasingly being used for circulatory support in patients with cardiogenic shock, although …

The use of temporary mechanical circulatory support in cardiogenic shock has increased
dramatically despite a lack of randomized controlled trials or evidence guiding clinical …

The Shock Academic Research Consortium is a multi-stakeholder group, including
representatives from the US Food and Drug Administration and other government agencies …

The introduction of Mission: Lifeline significantly increased timely access to percutaneous
coronary intervention for patients with ST-segment–elevation myocardial infarction (STEMI) …

Background Heart failure-related cardiogenic shock (HF-CS) accounts for an increasing
proportion of cases of CS in contemporary cardiac intensive care units. Whether the …

Owing to recent advances in early reperfusion strategies, pharmacological therapy,
standardized care, and the identification of vulnerable patient subsets, the prognosis of …

Cardiogenic shock (CS) is a heterogeneous syndrome reflecting a broad spectrum of shock
severity, diverse etiologies, variable cardiac function, different hemodynamic trajectories …

Background: Exposure to hyperoxia, a high arterial partial pressure of oxygen (PaO2), may
be associated with worse outcomes in patients receiving extracorporeal membrane …